π» PCVX: $2M LEAPS Put Bet Signals Hedging Ahead of Phase 3 Trial Risk
Institutional whale drops $1.5M on PCVX options. Someone just dropped $2 MILLION on long-dated puts in Vaxcyte (PCVX) - a clinical-stage biotech with its make-or-break Phase 3 trial data coming in Q4 Full analysis reveals entry points, price targets, and actionable trading strate
This post is for paying subscribers only
Already have an account? Sign in.